Enhancing a search for traditional medicinal plants with anthelmintic action by using wild type and stress reporter Caenorhabditis elegans strains as screening tools

International Journal for Parasitology

Volumn 44, Issue 5, 2014, Pages 291-298

  Kumarasingha, R ^a,b   Palombo, E A ^a   Bhave, M ^a   Yeo, T C ^c   Lim, D S L ^c   Tu, C L ^c   Shaw, J M ^a   Boag, P R ^b  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Sarawak Biodiversity Centre   (Malaysia)

Author keywords

Anthelmintic activity; Caenorhabditis elegans; Ethnomedicinal plant extracts

Indexed keywords

ANTHELMINTIC AGENT; ANTINEMATODAL AGENT; ANTIPARASITIC AGENT; DORAMECTIN; LANSIUM DOMESTICUM EXTRACT; LEVAMISOLE; LINARIANTHA BICOLOR EXTRACT; PICRIA FEL TERRAE EXTRACT; PLANT EXTRACT; TETRACERA AKARA EXTRACT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; DRUG; ETHNOBOTANY; MEDICINAL PLANT; NEMATODE; PLANT EXTRACT; TRADITIONAL MEDICINE;

ACANTHACEAE; ANTHELMINTIC ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILLENIACEAE; IN VITRO STUDY; LANSIUM DOMESTICUM; LINARIANTHA BICOLOR; MELIACEAE; NONHUMAN; PICRIA FEL TERRAE; SCROPHULARIACEAE; TETRACERA AKARA; WILD TYPE;

EAST MALAYSIA; MALAYSIA; SARAWAK;

CAENORHABDITIS ELEGANS; LANSIUM DOMESTICUM; PICRIA FEL-TERRAE;

ANTHELMINTIC ACTIVITY; CAENORHABDITIS ELEGANS; ETHNOMEDICINAL PLANT EXTRACTS;

ANIMALS; ANTHELMINTICS; CAENORHABDITIS ELEGANS; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LARVA; PLANT EXTRACTS; PLANTS, MEDICINAL; TRACHEOBIONTA;

EID: 84897029393     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2014.01.008     Document Type: Article

References (65)

1. Al-Adhroey A.H., Nor Z.M., Al-Mekhlafi H.M., Mahmud R. Ethnobotanical study on some Malaysian anti-malarial plants: a community based survey. J. Ethnopharmacol. 2010, 132:362-364.
2. Albonico M., Crompton D.W.T., Savioli L. Control strategies for human intestinal nematode infections. Advances in Parasitology 1999, 277-341. Academic Press. J.R. Baker, R. Muller, D. Rollinson (Eds.).
3. Anderson N., Martin P.J., Jarrett R.G. Mixtures of anthelmintics: a strategy against resistance. Aust. Vet. J. 1988, 65:62-64.
4. Anderson N., Martin P.J., Jarrett R.G. The efficacy of mixtures of albendazole sulphoxide and levamisole against sheep nematodes resistant to benzimidazole and levamisole. Aust. Vet. J. 1991, 68:127-132.
5. Barnes E.H., Dobson R.J., Barger I.A. Worm control and anthelmintic resistance: adventures with a model. Parasitol. Today 1995, 11:56-63.
6. Bartram D.J., Leathwick D.M., Taylor M.A., Geurden T., Maeder S.J. The role of combination anthelmintic formulations in the sustainable control of sheep nematodes. Vet. Parasitol. 2012, 186:151-158.
7. Beech R.N., Skuce P., Bartley D.J., Martin R.J., Prichard R.K., Gilleard J.S. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 2011, 138:160-174.
8. Blaxter M. Caenorhabditis elegans is a nematode. Science 1998, 282:2041-2046.
9. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
10. Bundy D.A., De Silva N.R. Can we deworm this wormy world?. Br. Med. Bull. 1998, 54:421-432.
11. Chai P.P.K. Medicinal Plants of Sarawak 2006, Lee Ming Press, Kuching.
12. Chan M.S., Medley G.F., Jamison D., Bundy D.a.P. The evaluation of potential global morbidity attributable to intestinal nematode infections. Parasitology 1994, 109:373-387.
13. Christensen H. Ethnobotany of the Iban & the Kelabit 2002, Forest Department Sarawak, Malaysia.
14. Csermely P., Korcsmáros T., Kiss H.J.M., London G., Nussinov R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol. Ther. 2013, 138:333-408.
15. Cvilink V., Lamka J., Skálová L. Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metabol. Rev. 2009, 41:8-26.
16. Desalermos A., Muhammed M., Glavis-Bloom J., Mylonakis E. Using Caenorhabditis elegans for antimicrobial drug discovery. Expert Opin. Drug Discov. 2011, 6:645-652.
17. Eguale T., Tadesse D., Giday M. In vitro anthelmintic activity of crude extracts of five medicinal plants against egg-hatching and larval development of Haemonchus contortus. J. Ethnopharmacol. 2011, 137:108-113.
18. Ewbank J.J., Zugasti O. C. elegans: model host and tool for antimicrobial drug discovery. Dis. Model Mech. 2011, 4:300-304.
19. Geary T.G., Thompson D.P. Caenorhabditis elegans: how good a model for veterinary parasites?. Vet. Parasitol. 2001, 101:371-386.
20. Hoste H., Jackson F., Athanasiadou S., Thamsborg S.M., Hoskin S.O. The effects of tannin-rich plants on parasitic nematodes in ruminants. Trends Parasitol. 2006, 22:253-261.
21. Hu L., Chen Z., Xie Y. New triterpenoid saponins from Picria fel-tarrae. J. Nat. Prod. 1996, 59:1186-1188.
22. Huang Y., De Bruyne T., Apers S., Ma Y., Claeys M., Vanden Berghe D., Pieters L., Vlietinck A. Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae. J. Nat. Prod. 1998, 61:757-761.
23. Jabbar A., Iqbal Z., Kerboeuf D., Muhammad G., Khan M.N., Afaq M. Anthelmintic resistance. the state of play revisited. Life Sci. 2006, 79:2413-2431.
24. Jackson F., Coop R.L. The development of anthelmintic resistance in sheep nematodes. Parasitology 2000, 120:S95-S107.
25. Kaewintajuk K., Cho P.Y., Kim S.Y., Lee E.S., Lee H.K., Choi E.B., Park H. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans. Parasitol. Res. 2010, 107:27-30.
26. Kamath R.S., Martinez-Campos M., Zipperlen P., Fraser A.G., Ahringer J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2001, 2:1-10.
27. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., Mäser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
28. Kaminsky R., Gauvry N., Schorderet Weber S., Skripsky T., Bouvier J., Wenger A., Schroeder F., Desaules Y., Hotz R., Goebel T., Hosking B.C., Pautrat F., Wieland-Berghausen S., Ducray P. Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate. Parasitol. Res. 2008, 103:931-939.
29. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 2004, 20:477-481.
30. Kaplan R.M., Vidyashankar A.N. An inconvenient truth: global worming and anthelmintic resistance. Vet. Parasitol. 2012, 186:70-78.
31. Kappagoda S., Singh U., Blackburn B.G. Antiparasitic therapy. Mayo Clin. Proc. 2011, 86:561-583.
32. Kapulkin V., Hiester B.G., Link C.D. Compensatory regulation among ER chaperones in C. elegans. FEBS Lett. 2005, 579:3063-3068.
33. Katiki L.M., Ferreira J.F.S., Zajac A.M., Masler C., Lindsay D.S., Chagas A.C.S., Amarante A.F.T. Caenorhabditis elegans as a model to screen plant extracts and compounds as natural anthelmintics for veterinary use. Vet. Parasitol. 2011, 182:264-268.
34. Kenyon C. 28 Environmental factors and gene activities that influence life span. C. elegans II 1997, 791-814. Cold Spring Harbor Laboratory Press, New York. second ed. D.L. Riddle, T. Blumenthal, B.J. Meyer, J.R. Priess (Eds.).
35. Kiontke, K., Fitch, D.H., 2005. The phylogenetic relationships of Caenorhabditis and other rhabditids. In: WormBook, doi:. http://www.wormbook.org.
36. Leathwick D.M., Hosking B.C. Managing anthelmintic resistance. Modelling strategic use of a new anthelmintic class to slow the development of resistance to existing classes. NZ Vet. J. 2009, 57:203-207.
37. Leathwick D.M., Hosking B.C., Bisset S.A., Mckay C.H. Managing anthelmintic resistance. Is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class?. NZ Vet. J. 2009, 57:181-192.
38. Leathwick D.M., Waghorn T.S., Miller C.M., Candy P.M., Oliver A.M.B. Managing anthelmintic resistance - use of a combination anthelmintic and leaving some lambs untreated to slow the development of resistance to ivermectin. Vet. Parasitol. 2012, 187:285-294.
39. Lenaerts I., Walker G.A., Van Hoorebeke L., Gems D., Vanfleteren J.R. Dietary restriction of Caenorhabditis elegans by axenic culture reflects nutritional requirement for constituents provided by metabolically active microbes. J. Gerontol. A 2008, 63:242-252.
40. Libina N., Berman J.R., Kenyon C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 2003, 115:489-502.
41. Link C.D., Johnson C.J. Reporter transgenes for study of oxidant stress in Caenorhabditis elegans. Chandan K 2002, 497-505. Methods in Enzymology, Academic Press, New York. L.P. Sen (Ed.).
42. Link C.D., Cypser J.R., Johnson C.J., Johnson T.E. Direct observation of stress response in Caenorhabditis elegans using a reporter transgene. Cell Stress Chaperones 1999, 4:235-242.
43. Liu Z.L., Liu J.P., Zhang A.L., Wu Q., Ruan Y., Lewith G., Visconte D. Chinese herbal medicines for hypercholesterolemia. Cochrane Database Syst. Rev. 2011, 7. CD008305. 10.1002/14651858.
44. Mackenzie C.D., Geary T.G. Addressing the current challenges to finding new anthelminthic drugs. Exp. Rev. Anti Infect. Ther. 2013, 11:539-541.
45. Manosroi A., Jantrawut P., Sainakham M., Manosroi W., Manosroi J. Anticancer activities of the extract from Longkong (Lansium domesticum) young fruits. Pharm. Biol. 2012, 50:1397-1407.
46. Monzon R.B., Alvior J.P., Luczon L.L., Morales A.S., Mutuc F.E. Larvicidal potential of five Philippine plants against Aedes aegypti (Linnaeus) and Culex quinquefasciatus (Say). Southeast Asian J. Trop. Med. Public Health 1994, 25:755-759.
47. Morley J.F., Morimoto R.I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 2004, 15:657-664.
48. Nishizawa M., Emura M., Yamada H., Shiro M., Chairul, Hayashi Y., Tokuda H. Isolation of a new cycloartanoid triterpene from leaves of Lansium domesticum novel skin-tumor promotion inhibitors. Tetrahedron Lett. 1989, 30:5615-5618.
49. Omar S., Zhang J., Mackinnon S., Leaman D., Durst T., Philogene B.J., Arnason J.T., Sanchez-Vindas P.E., Poveda L., Tamez P.A., Pezzuto J.M. Traditionally-used antimalarials from the Meliaceae. Curr. Top. Med. Chem. 2003, 3:133-139.
50. Perry B.D., Randolph T.F. Improving the assessment of the economic impact of parasitic diseases and of their control in production animals. Vet. Parasitol. 1999, 84:145-168.
51. Prichard R. Anthelmintic resistance. Vet. Parasitol. 1994, 54:259-268.
52. Prichard R.K., Hall C.A., Kelly J.D., Martin I.C., Donald A.D. The problem of anthelmintic resistance in nematodes. Aust. Vet. J. 1980, 56:239-251.
53. Qu H.B., Dengfeng W., Wu T., Marjoribanks J., Ying S., Haijun J., Zhang J., Hu L. Chinese herbal medicine in the treatment of ectopic pregnancy. Cochrane Database Syst. Rev. 2011, 6. CD006224. 10.1002/14651858.
54. Scott I., Pomroy W.E., Kenyon P.R., Smith G., Adlington B., Moss A. Lack of efficacy of monepantel against Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet. Parasitol. 2013, 198:166-171.
55. Squiban B., Kurz C.L. C. elegans: an all in one model for antimicrobial drug discovery. Curr. Drug Targets 2011, 12:967-977.
56. Stepek G., Buttle D.J., Duce I.R., Behnke J.M. Human gastrointestinal nematode infections: are new control methods required?. Int. J. Exp. Pathol. 2006, 87:325-341.
57. Stiernagle, T., 2006. Maintenance of C. elegans. In: WormBook, doi: ,. http://www.wormbook.org.
58. Sutherland I.A., Leathwick D.M. Anthelmintic resistance in nematode parasites of cattle: a global issue?. Trends Parasitol. 2011, 27:176-181.
59. Sutherland I.A., Moen I.C., Leathwick D.M. Increased burdens of drug-resistant nematodes due to anthelmintic treatment. Parasitology 2002, 125:375-381.
60. Trent C., Tsuing N., Horvitz H.R. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 1983, 104:619-647.
61. Waller P.J. Anthelmintic resistance. Vet. Parasitol. 1997, 72:391-412.
62. Wang J., Robida-Stubbs S., Tullet J.M.A., Rual J., Vidal M., Keith Blackwell T. RNAi screening implicates a SKN-1-dependent transcriptional response in stress resistance and longevity deriving from translation inhibition. PLoS Genet. 2010, 6.
63. Wolstenholme A.J., Fairweather I., Prichard R., Von Samson-Himmelstjerna G., Sangster N.C. Drug resistance in veterinary helminths. Trends Parasitol. 2004, 20:469-476.
64. Xu H.B., Jiang R.H., Chen X.Z., Li L. Chinese herbal medicine in treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis. J. Ethnopharmacol. 2012, 143:701-708.
65. Yadav P., Singh R. A review on anthelmintic drugs and their future scope. Int. J. Pharm. Pharm. Sci. 2011, 3:17-21.